Report Categories
View AllRecent Articles
View All
Dogwood Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Preclinical Development
CRDO Q1 2026 Earnings Strong EPS Beat Drives DoubleDigit Stock Surge
LASR Q1 2026 Earnings EPS Surges Past Expectations by Over 126
WFC Q1 2026 Earnings EPS Slightly Tops Estimates Amid Mixed Market Sentiment
BNR Q3 2022 Earnings Narrower Loss Surprises Wall Street as Stock Drops 11 on Broader Biotech Selloff